Best for
Mobile
How to buy Edwards Lifesciences Corporation shares
Own Edwards Lifesciences Corporation shares in just a few minutes. Share price changes are updated daily.
Fact checked
Edwards Lifesciences Corporation (EW) is a leading medical devices business based in the US. Edwards Lifesciences Corporation is listed on the NYSE and employs 13,900 staff. All prices are listed in US Dollars.
How to buy shares in Edwards Lifesciences Corporation
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: EW in this case.
- Research Edwards Lifesciences Corporation shares. The platform should provide the latest information available.
- Buy your Edwards Lifesciences Corporation shares. It's that simple.
What's in this guide?
- Can I buy shares in Edwards Lifesciences Corporation?
- Edwards Lifesciences Corporation shares summary
- Compare share dealing platforms
- Is Edwards Lifesciences Corporation stock a buy or sell?
- Can I short Edwards Lifesciences Corporation shares?
- Is Edwards Lifesciences Corporation suitable for ethical investing?
- Are Edwards Lifesciences Corporation shares over-valued?
- Edwards Lifesciences Corporation's financials
- How volatile are Edwards Lifesciences Corporation shares?
- Does Edwards Lifesciences Corporation pay a dividend?
- Have Edwards Lifesciences Corporation shares ever split?
- Other common questions
Edwards Lifesciences Corporation share price
Use our graph to track the performance of EW stocks over time.Edwards Lifesciences Corporation shares at a glance
Information last updated 2021-01-23.
| 52-week range | $51.5067 - $92.08 |
|---|---|
| 50-day moving average | $87.5027 |
| 200-day moving average | $81.5104 |
| Wall St. target price | $94.35 |
| PE ratio | 67.6047 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $1.265 |
Invest in Edwards Lifesciences Corporation shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Edwards Lifesciences Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Edwards Lifesciences Corporation under- or over-valued?
Valuing Edwards Lifesciences Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Edwards Lifesciences Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Edwards Lifesciences Corporation's P/E ratio
Edwards Lifesciences Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 68x. In other words, Edwards Lifesciences Corporation shares trade at around 68x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Edwards Lifesciences Corporation's PEG ratio
Edwards Lifesciences Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.2397. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Edwards Lifesciences Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Edwards Lifesciences Corporation's EBITDA
Edwards Lifesciences Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.4 billion.
The EBITDA is a measure of a Edwards Lifesciences Corporation's overall financial performance and is widely used to measure a its profitability.
Edwards Lifesciences Corporation financials
| Revenue TTM | $4.4 billion |
|---|---|
| Operating margin TTM | 29.85% |
| Gross profit TTM | $3.2 billion |
| Return on assets TTM | 12.77% |
| Return on equity TTM | 19.79% |
| Profit margin | 18.18% |
| Book value | $6.759 |
| Market capitalisation | $53.3 billion |
TTM: trailing 12 months
How to short and sell Edwards Lifesciences Corporation shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "EW.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 4.6 million Edwards Lifesciences Corporation shares held short by investors – that's known as Edwards Lifesciences Corporation's "short interest". This figure is 12.9% down from 5.3 million last month.
There are a few different ways that this level of interest in shorting Edwards Lifesciences Corporation shares can be evaluated.
Edwards Lifesciences Corporation's "short interest ratio" (SIR)
Edwards Lifesciences Corporation's "short interest ratio" (SIR) is the quantity of Edwards Lifesciences Corporation shares currently shorted divided by the average quantity of Edwards Lifesciences Corporation shares traded daily (recently around 2.2 million). Edwards Lifesciences Corporation's SIR currently stands at 2.09. In other words for every 100,000 Edwards Lifesciences Corporation shares traded daily on the market, roughly 2090 shares are currently held short.
However Edwards Lifesciences Corporation's short interest can also be evaluated against the total number of Edwards Lifesciences Corporation shares, or, against the total number of tradable Edwards Lifesciences Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Edwards Lifesciences Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Edwards Lifesciences Corporation shares in existence, roughly 10 shares are currently held short) or 0.0076% of the tradable shares (for every 100,000 tradable Edwards Lifesciences Corporation shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Edwards Lifesciences Corporation.
Find out more about how you can short Edwards Lifesciences Corporation stock.
Edwards Lifesciences Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Edwards Lifesciences Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Edwards Lifesciences Corporation's total ESG risk score
Total ESG risk: 21.68
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Edwards Lifesciences Corporation's overall score of 21.68 (as at 01/01/2019) is pretty good – landing it in it in the 24th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Edwards Lifesciences Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Edwards Lifesciences Corporation's environmental score
Environmental score: 4.78/100
Edwards Lifesciences Corporation's environmental score of 4.78 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Edwards Lifesciences Corporation's social score
Social score: 13.43/100
Edwards Lifesciences Corporation's social score of 13.43 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Edwards Lifesciences Corporation's governance score
Governance score: 10.96/100
Edwards Lifesciences Corporation's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Edwards Lifesciences Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Edwards Lifesciences Corporation's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Edwards Lifesciences Corporation scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Edwards Lifesciences Corporation has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Edwards Lifesciences Corporation was last rated for ESG on: 2019-01-01.
| Total ESG score | 21.68 |
|---|---|
| Total ESG percentile | 24.1 |
| Environmental score | 4.78 |
| Environmental score percentile | 6 |
| Social score | 13.43 |
| Social score percentile | 6 |
| Governance score | 10.96 |
| Governance score percentile | 6 |
| Level of controversy | 2 |
Edwards Lifesciences Corporation share dividends
We're not expecting Edwards Lifesciences Corporation to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have Edwards Lifesciences Corporation's shares ever split?
Edwards Lifesciences Corporation's shares were split on a 3:1 basis on 1 June 2020. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Edwards Lifesciences Corporation shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Edwards Lifesciences Corporation shares which in turn could have impacted Edwards Lifesciences Corporation's share price.
Edwards Lifesciences Corporation share price volatility
Over the last 12 months, Edwards Lifesciences Corporation's shares have ranged in value from as little as $51.5067 up to $92.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Edwards Lifesciences Corporation's is 0.9732. This would suggest that Edwards Lifesciences Corporation's shares are less volatile than average (for this exchange).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Edwards Lifesciences Corporation overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Frequently asked questions
More guides on Finder
-
How to buy Transportation and Logistics Systems shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert